188 studies found for:    Open Studies | "Fatty Liver"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Genetic Studies of Non-Alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Liver Transplantation;   Genetics
2 Recruiting Fatty Liver Disease Collaborative Research in China
Conditions: Fatty Liver;   Fatty Liver, Alcoholic;   Non-alcoholic Fatty Liver Disease
3 Recruiting An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
Conditions: Psoriasis Chronic;   Liver Fibrosis;   Fatty Liver;   Non-alcoholic Fatty Liver Disease
Intervention: Device: Transient elastography
4 Recruiting Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease;   NAFLD;   Fatty Liver, Nonalcoholic;   Nonalcoholic Fatty Liver Disease
5 Recruiting Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
Conditions: Fatty Liver;   Hepatic Steatosis;   Liver Steatosis
Interventions: Device: FibroTouch;   Procedure: Liver Biopsy
6 Unknown  Fatty Liver in Inflammatory Bowel Disease (IBD) Patients
Conditions: Inflammatory Bowel Disease;   Fatty Liver
Intervention: Other: clinical evaluation
7 Recruiting Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition: Fatty Liver
Interventions: Drug: Vitamin E 200 IU/d;   Drug: Vitamin E 400 IU/d;   Drug: Vitamin E 800 IU/d;   Behavioral: Diet and Exercise
8 Recruiting Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver
Condition: Fatty Liver
Intervention: Dietary Supplement: Probiotics and fruit fibre
9 Not yet recruiting Fatty Liver Disease in Obese Children
Conditions: Obesity;   Nonalcoholic Fatty Liver Disease;   Cardiovascular Disease
Interventions: Dietary Supplement: N-acetyl cysteine 600 mg once/day;   Dietary Supplement: N-acetyl cysteine 600mg twice/day;   Other: Placebo twice/day
10 Recruiting Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: Liver Disease;   Fatty Liver
11 Recruiting Fatty Liver Study in Patients With Type II Diabetes
Conditions: Type II Diabetes;   Nonalcoholic Fatty Liver
Interventions: Drug: DPP4 inhibitor;   Drug: Pioglitazone;   Drug: Lantus insulin
12 Unknown  Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Dyslipidemias;   Diabetes Mellitus
Interventions: Drug: atorvastatin;   Drug: Vitamin E
13 Recruiting Genetics of Fatty Liver Disease in Children
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Other: ogtt;   Other: genotyping;   Other: abdominal and liver magnetic resonance imaging;   Other: stool sample;   Other: liver biopsy
14 Recruiting Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Conditions: Insulin Resistance;   Nonalcoholic Fatty Liver Disease
15 Unknown  Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Drug: atorvastatin;   Behavioral: lifestyle counseling
16 Recruiting A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
Conditions: Psoriasis;   Nonalcoholic Fatty Liver Disease
17 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Intervention: Other: Omega diet
18 Unknown  Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Procedure: Phlebotomy
19 Recruiting Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
Conditions: Type 2 Diabetes;   Non-alcoholic Fatty Liver Disease
Intervention: Drug: Sitagliptin
20 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years